Skip to main content

Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About
Trending Topics
    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Entertainment & Media
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor, Employment, and Benefits
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations
    Industries

    View All

    • Aviation
    • Cannabis
    • Consumer
    • Energy
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Nonprofit Organizations
    • Real Estate
    • Sports & Stadiums
    • Technology
    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Environmental, Social, and Governance (ESG)

      We help clients create positive return on investments in people, products, and the planet.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    • Women in Dealmaking

      We provide strategic counsel on complex corporate transactions and unite dynamic women in the dealmaking arena.

    1. Home
    2. Insights
    3. Alerts
    4. State sovereign immunity, like tribal sovereign immunity, does not protect from IPR proceedings

      Alerts

    Alert / Intellectual Property

    State sovereign immunity, like tribal sovereign immunity, does not protect from IPR proceedings

    July 3, 2019

    LinkedInX (Twitter)EmailCopy URL

    By Leslie Hartford and Jason Kravitz

    State sovereign immunity does not prevent inter partes review (IPR) proceedings asserted against patents owned by, or assigned to, states. In Regents of Univ. of Minnesota v. LSI Corp., the Federal Circuit found that because an IPR proceeding is more like a government agency enforcement action than a civil litigation as well as an adjudication of a public right, and because state and tribal sovereign immunity does not materially differ with regard to IPR proceedings, state sovereign immunity also does not apply to IPR proceedings.

    This month, the Federal Circuit announced a notable change in the treatment of state-owned patents during IPRs, holding in LSI Corp. that, like patents owned by Native American Tribes, where tribal immunity did not apply, state sovereign immunity does not apply during IPRs before the Patent Trial and Appeal Board (PTAB). See No. 2018-1559, 2019 WL 2479596 (Fed. Cir. June 14, 2019).

    States typically enjoy immunity from lawsuits brought by private parties in an Article III forum—including federal courts and “agency adjudications brought by private parties that are similar to court adjudications.” However, this protection “does not apply to suits brought by the United States, including agency proceedings commenced by the United States.” The Supreme Court has held, therefore, that a federal agency may bring an enforcement action against a state even if it is based on “information supplied by a private party.”

    The procedural format of an IPR and the extent of the sovereign immunity provide the basis for the court’s decision in LSI. Specifically, the court found critical the fact that the Director of the United States Patent and Trademark Office (USPTO), an appointed official, decides to proceed with an IPR, rendering the action more like a government agency proceeding than private litigation. Additionally, because IPRs examine the propriety of a government-issued patents, the process may be considered “an adjudication of public rights,” landing the proceeding outside the scope of sovereign immunity.

    The court distinguished IPR proceedings from typical civil litigation—to which sovereign immunity would normally apply—unless waived, and stated that IPR proceedings “are essentially agency reconsideration of a prior patent grant” and that the primary focus of the PTAB is determining whether a patent was granted in error, rather than resolving a dispute between two adversarial parties. In other words, IPRs are more akin to a government “agency enforcement action[s]” than civil litigations.

    While this decision diverges from previous treatment, which shielded states and their operating entities, such as state universities, from IPR challenges, the court found that sovereign immunity was similar to Native American tribal sovereign immunity, and therefore the ruling comports with the 2018 decision in Saint Regis Mohawk Tribe v. Mylan Pharm. Inc., 896 F.3d 1322 (Fed. Cir. 2018), cert. denied, 139 S. Ct. 1547 (2019). The court in Saint Regis affirmed the PTAB’s decision denying sovereign immunity to the Saint Regis Mohawk Tribe and concluded, “IPR is more like an agency enforcement action than a civil suit brought by a private party… [and t]hus we conclude that tribal immunity is not implicated.” The court further held that because an “IPR represents the sovereign’s reconsideration of the initial patent grant, the differences between state and tribal sovereign immunity do not warrant a different result than Saint Regis. We, therefore, conclude that state sovereign immunity does not apply to IPR proceedings.”

    Although sovereign immunity does not apply in IPRs, state universities may still rely on sovereign immunity in other patent litigation contexts, such as in seeking dismissal of declaratory judgment actions where the state university has not asserted affirmative patent infringement claims itself.

    Practices

    Intellectual Property

    Industries

    Higher Education

    Insights And Happenings

    • Alert

      USPTO proposes new rules about burdens when a patentee moves to amend its challenged claims before the PTAB

      Nov 4, 2019
    • Alert

      New trademark protection considerations for cannabis/CBD brands

      July 16, 2019
    The foregoing has been prepared for the general information of clients and friends of the firm. It is not meant to provide legal advice with respect to any specific matter and should not be acted upon without professional counsel. If you have any questions or require any further information regarding these or other related matters, please contact your regular Nixon Peabody LLP representative. This material may be considered advertising under certain rules of professional conduct.

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • Cookie Preferences
    • Privacy Policy
    • Terms of Use
    • Accessibility Statement
    • Statement of Client Rights
    • Purchase Order Terms & Conditions
    • Nixon Peabody International LLC
    • PAL
    © 2025 Nixon Peabody. All rights reserved